1. Otte M*, Zafrakas M* et al. MAGE-A gene expression profile in primary breast cancer. Cancer Research 2001; 61: 6682-6687 (*These authors equally contributed to this work) (Impact factor: 8.164, Citations: 110).

2. Zafrakas M et al. Expression analysis of Mammaglobin A (SCGB2A2) and Lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies. BMC Cancer 2006; 6: 88 (Impact factor: 3.260, Citations: 60).

3. Zafrakas M *, Chorovicer M * et al. Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue. (*These authors equally contributed to this work). Int J Cancer 2006; 118: 1453-1459. (Impact Factor: 4.919, Citations:  32)

4. Zafrakas M et al. Genome-wide microarray gene expression, array-CGH analysis and telomerase activity in advanced ovarian endometriosis: High degree of differentiation rather than malignant potential. Int J Mol Med 2008; 21: 335-344 (Impact factor: 1.746, Citations:  36).

5. J Veeck, M Chorovicer, A Naami, E Breuer, M Zafrakas, et al. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene 2008; 27, 865–876 (Impact Factor 8.459, Citations 48)